TETI, ELISABETTA

TETI, ELISABETTA  

Dipartimento di Medicina dei sistemi  

Mostra records
Risultati 1 - 20 di 87 (tempo di esecuzione: 0.028 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-2025 A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity. Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V Intervento a convegno
1-gen-2024 A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R Intervento a convegno
1-gen-2016 Abnormal cortical sources of resting state electroencephalographic rhythms in single treatment-naïve HIV individuals: A statistical z-score index Babiloni, C; Pennica, A; Del Percio, C; Noce, G; Cordone, S; Muratori, C; Ferracuti, S; Donato, N; Di Campli, F; Gianserra, L; Teti, E; Aceti, A; Soricelli, A; Viscione, M; Limatola, C; Andreoni, M; Onorati, P Articolo su rivista
1-feb-2019 Abnormal elevation of international normalized ratio in a patient during the coadministration of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and warfarin: a case report Malagnino, V; Cerva, C; Teti, E; Maffongelli, G; Andreoni, M; Sarmati, L Articolo su rivista
1-gen-2022 An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. Bellocchi, Mc; Carioti, L; Scutari, R; Iannetta, M; Piermatteo, L; Alkhatib, M; Tedde, S; Duca, L; Coppola, L; Malagnino, V; Crea, A; Ansaldo, L; D’Anna, S; Santoro, Mm; Bertoli, A; Di Lorenzo, A; Salpini, R; Svicher, V; Teti, E; Braccialarghe, N; Cavasio, Ra; Sarmati, L; Andreoni, M; Ceccherini-Silberstein, F Intervento a convegno
1-gen-2025 An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V Intervento a convegno
1-gen-2016 Antiretroviral therapy affects the z-score index of deviant cortical EEG rhythms in naïve HIV individuals Babiloni, C; Pennica, A; Nullc, N; Noce, G; Cordone, S; Lopez, S; Berry, K; Muratori, C; Ferracuti, S; Roma, P; Correr, V; Nullf, N; Gianserra, L; Ciullini, L; Aceti, A; Soricelli, A; Teti, E; Viscione, M; Limatola, C; Onorati, P; Capotosto, P; Andreoni, M Articolo su rivista
1-gen-2022 B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications Iannetta, M; Landi, D; Cola, G; Campogiani, L; Malagnino, V; Teti, E; Coppola, L; Di Lorenzo, A; Fraboni, D; Buccisano, F; Grelli, S; Mozzani, M; Zingaropoli, Ma; Ciardi, Mr; Nisini, R; Bernardini, S; Andreoni, M; Marfia, Ga; Sarmati, L Articolo su rivista
1-giu-2021 Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in {SARS}-{CoV}-2 infected patients: a single center study Iannetta, M; Buccisano, F; Fraboni, D; Malagnino, V; Campogiani, L; Teti, E; Spalliera, I; Rossi, B; Di Lorenzo, A; Palmieri, R; Crea, A; Zordan, M; Vitale, P; Voso, Mt; Andreoni, M; Sarmati, L Articolo su rivista
3-lug-2022 Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice Armenia, D; Forbici, F; Bertoli, A; Berno, G; Malagnino, V; Gagliardini, R; Borghi, V; Gennari, W; Cicalini, S; Buonomini, A; Teti, E; Lanini, S; Latini, A; Sarmati, L; Mussini, C; Andreoni, M; Antinori, A; Perno, Cf; Ceccherini-Silberstein, F; Santoro, M Articolo su rivista
1-gen-2016 Brain and cognitive functions in two groups of naïve HIV patients selected for a different plan of antiretroviral therapy: A qEEG study Babiloni, C; Pennica, A; Capotosto, P; Onorati, P; Muratori, C; Ferracuti, S; Roma, P; Correr, V; Piccinni, E; Noce, G; Del Percio, C; Cordone, S; Limatola, C; Soricelli, A; Di Campli, F; Gianserra, L; Ciullini, L; Aceti, A; Viscione, M; Teti, E; Sarmati, L; Andreoni, M Articolo su rivista
1-gen-2019 Cerebral Multishell Diffusion Imaging Parameters are Associated with Blood Biomarkers of Disease Severity in HIV Infection Garaci, F; Picchi, E; Di Giuliano, F; Lanzafame, S; Minosse, S; Manenti, G; Pistolese, Ca; Sarmati, L; Teti, E; Andreoni, M; Floris, R; Toschi, N Articolo su rivista
1-gen-2024 Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV. Magnapera, 1a; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Salpini, R; Svicher, V Intervento a convegno
1-gen-2024 Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV mono-infection, that parallels HDV replicative and cytolytic activity. Piermatteo, 1l; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R Intervento a convegno
1-gen-2025 Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity. D’Anna, S; Piermatteo, L; Magnapera, A; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, L; Milella, M; Saracino, Al; Ciancio, Al; Silberstein, C; F, ; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R Intervento a convegno
1-gen-2024 Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Svicher, V; Salpini, R Intervento a convegno
1-gen-2024 Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir. Salpini, 1r; D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, A; Abate, Ml; Olivero, A; Gaeta, G; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher., V Intervento a convegno
1-gen-2026 Chronic HDV Infection Shows Higher HBsAg Isoform Levels than HBV Infection, Paralleling HDV Replicative Activity D'Anna, S; Piermatteo, L; Magnapera, A; Grossi, I; Tramontozzi, C; Olivero, A; Duca, L; Torre, G; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Grelli, S; Paba, P; Bertoli, A; Ceccherini-Silberstein, F; Baiocchi, L; Francioso, S; Lenci, I; Milella, M; Saracino, A; Ciancio, A; Brancaccio, G; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V Articolo su rivista
1-gen-2022 Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. Bellocchi, M; Carioti, L; Scutari, R; Iannetta, M; Piermatteo, L; Alkhatib, M; Tedde, S; Duca, L; Coppola, L; Malagnino, V; Crea, A; Ansaldo, L; D’Anna, S; Santoro, Mm; Bertoli, A; Di Lorenzo, A; Salpini, R; Svicher, V; Teti, E; Braccialarghe, N; Cavasio, Ra; Sarmati, L; Andreoni, M; Ceccherini Silberstein, F Articolo su rivista
1-gen-2025 Clinical and laboratory parameters correlated to HDV undetectability after 48 weeks of bulevirtide Di Lorenzo, N; D’Anna, S; Kontogiannis, D; Sorace, C; Crea, A; Teti, E; Malagnino, V; Piermatteo, L; Grossi, I; Castelli, C; Carreri, B; Nezzo, M; Salbuzzi, F; Iannetta, M; Geretti, A; Svicher, V; Salpini, R; Sarmati, L Intervento a convegno